Form 8-K - Current report:
SEC Accession No. 0001213900-23-068621
Filing Date
2023-08-17
Accepted
2023-08-17 17:20:10
Documents
14
Period of Report
2023-08-17
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183783-8k_aditxt.htm   iXBRL 8-K 30824
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ADITXT, INC ea183783ex3-1_aditxt.htm EX-3.1 8587
3 PRESS RELEASE DATED AUGUST 17, 2023 ea183783ex99-1_aditxt.htm EX-99.1 8055
  Complete submission text file 0001213900-23-068621.txt   229003

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20230817.xsd EX-101.SCH 3009
5 XBRL LABEL FILE adtx-20230817_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20230817_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea183783-8k_aditxt_htm.xml XML 3400
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 231182960
SIC: 2834 Pharmaceutical Preparations